Argenx Se (ARGX) Total Current Liabilities (2015 - 2025)

Argenx Se (ARGX) posted Total Current Liabilities of $1.3 billion for Q4 2025, down 99.87% on a QoQ basis from $1041.9 billion in Q2 2025, and up 97.07% year-over-year from $669.9 million in Q4 2024.

Argenx Se (ARGX) Total Current Liabilities (2015 - 2025) Analysis & Trends

Argenx Se's Total Current Liabilities history runs 11 years deep, the most recent figure standing at $1.3 billion for Q4 2025.

  • Quarterly Total Current Liabilities rose 97.07% year-over-year to $1.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 billion (up 97.07% YoY) and the FY2025 annual result came in at $1.3 billion, up 97.07% from the prior year.
  • Total Current Liabilities was $1.3 billion for Q4 2025 at Argenx Se, down from $1041.9 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1041.9 billion in Q2 2025 and bottomed at $244.0 million in Q2 2021.
  • A 5-year average of $104.6 billion and a median of $370.4 million in 2023 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2021 — Total Current Liabilities declined 5.62% — and 2025, when it jumped 208435.53%.
  • Argenx Se's Total Current Liabilities stood at $301.2 million in 2021, then advanced by 0.34% to $302.3 million in 2022, then surged by 39.94% to $423.0 million in 2023, then soared by 58.38% to $669.9 million in 2024, then jumped by 97.07% to $1.3 billion in 2025.
  • Business Quant data shows ARGX's Total Current Liabilities at $1.3 billion in Q4 2025, $1041.9 billion in Q2 2025, and $669.9 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 56.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 66.94 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 13.42 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.81 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 289.60 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 1.35 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.32 Bn
Jun 30, 2025 1,041.90 Bn
Dec 31, 2024 669.92 Mn
Jun 30, 2024 499.63 Mn
Dec 31, 2023 422.99 Mn
Jun 30, 2023 317.79 Mn
Dec 31, 2022 302.28 Mn
Jun 30, 2022 264.60 Mn
Dec 31, 2021 301.24 Mn
Jun 30, 2021 244.04 Mn
Dec 31, 2020 319.17 Mn
Jun 30, 2020 217.90 Mn
Dec 31, 2019 177.05 Mn
Jun 30, 2019 115.05 Mn
Dec 31, 2018 45.72 Mn
Jun 30, 2018 32.26 Mn
Dec 31, 2017 28.87 Mn
Jun 30, 2017 38.74 Mn
Dec 31, 2016 34.90 Mn
Dec 31, 2015 9.52 Mn